Published November 2018 | Version v1
Journal article Metadata-only

IDEAL 2a Phase II Study of Ultrafocal Brachytherapy for Low- and Intermediate-risk Prostate Cancer

Creators

  • 1. Department of Radiation Oncology, Institut Universitaire du Cancer de Toulouse, Toulouse (France)
  • 2. Department of Radiology, Institut Universitaire du Cancer de Toulouse, Toulouse (France)
  • 3. Department of Biostatistics, Institut Universitaire du Cancer de Toulouse, Toulouse (France)
  • 4. Department of Biophysics, Institut Universitaire du Cancer de Toulouse, Toulouse (France)

Description

Focal therapy of prostate cancer requires precise positioning of therapeutic agents within well-characterized index tumors (ITs). We assessed the feasibility of low-dose-rate ultrafocal brachytherapy.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ijrobp.2018.01.066

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2018.01.066;
PII
S0360301618301809;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
102
Journal Issue
4
Journal Page Range
p. 903-911
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
53017250
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BRACHYTHERAPY; DOSE RATES; DRUGS; HAZARDS; NEOPLASMS; PROSTATE
Descriptors DEC
BODY; DISEASES; GLANDS; MALE GENITALS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; RADIOTHERAPY; THERAPY

Optional Information

Copyright
Copyright (c) 2018 Elsevier Inc. All rights reserved.